<doc:document xmlns:doc="http://www.elsevier.com/xml/document/schema" xmlns:dp="http://www.elsevier.com/xml/common/doc-properties/schema" xmlns:cps="http://www.elsevier.com/xml/common/consyn-properties/schema" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dct="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:oa="http://vtw.elsevier.com/data/ns/properties/OpenAccess-1/" xmlns:bam="http://vtw.elsevier.com/data/voc/ns/bam-vtw-1/" xmlns:cp="http://vtw.elsevier.com/data/ns/properties/Copyright-1/" xmlns:cja="http://www.elsevier.com/xml/cja/schema" xmlns:ja="http://www.elsevier.com/xml/ja/schema" xmlns:bk="http://www.elsevier.com/xml/bk/schema" xmlns:ce="http://www.elsevier.com/xml/common/schema" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:cals="http://www.elsevier.com/xml/common/cals/schema" xmlns:tb="http://www.elsevier.com/xml/common/table/schema" xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/schema" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/schema" xmlns:xlink="http://www.w3.org/1999/xlink"><rdf:RDF><rdf:Description rdf:about="http://dx.doi.org/10.1016/j.dib.2021.107771"><dct:format>application/xml</dct:format><dct:title>Data on the frequency and causes of icteric interference in clinical chemistry laboratory tests</dct:title><dct:creator>Anna E. Merrill</dct:creator><dct:creator>Sandhya Mainali</dct:creator><dct:creator>Matthew D. Krasowski</dct:creator><dct:subject><rdf:Bag><rdf:li>Alcoholic liver disease</rdf:li><rdf:li>Biliary tract diseases</rdf:li><rdf:li>Bilirubin</rdf:li><rdf:li>Clinical chemistry tests</rdf:li><rdf:li>Jaundice</rdf:li><rdf:li>Viral hepatitis</rdf:li></rdf:Bag></dct:subject><dct:description>Data in Brief 40 (2022). doi:10.1016/j.dib.2021.107771</dct:description><prism:aggregationType>journal</prism:aggregationType><prism:publicationName>Data in Brief</prism:publicationName><prism:copyright>&#169; 2021 The Authors. Published by Elsevier Inc.</prism:copyright><dct:publisher>Elsevier Inc.</dct:publisher><prism:issn>2352-3409</prism:issn><prism:volume>40</prism:volume><prism:coverDisplayDate>February 2022</prism:coverDisplayDate><prism:doi>10.1016/j.dib.2021.107771</prism:doi><prism:url>http://dx.doi.org/10.1016/j.dib.2021.107771</prism:url><dct:identifier>doi:10.1016/j.dib.2021.107771</dct:identifier><bam:articleNumber>107771</bam:articleNumber><oa:openAccessInformation><oa:openAccessStatus xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://vtw.elsevier.com/data/voc/oa/OpenAccessStatus#Full</oa:openAccessStatus><oa:openAccessEffective xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">2021-12-28T16:56:49Z</oa:openAccessEffective><oa:sponsor xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><oa:sponsorType>http://vtw.elsevier.com/data/voc/oa/SponsorType#Author</oa:sponsorType></oa:sponsor><oa:userLicense xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://creativecommons.org/licenses/by/4.0/</oa:userLicense></oa:openAccessInformation><cp:licenseLine xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">This is an open access article under the CC BY license.</cp:licenseLine></rdf:Description></rdf:RDF><dp:document-properties><dp:aggregation-type>Journals</dp:aggregation-type><dp:version-number>S300.1</dp:version-number></dp:document-properties><ja:article docsubtype="dat" version="5.6" xml:lang="en"><ja:item-info><ja:jid>DIB</ja:jid><ja:aid>107771</ja:aid><ce:article-number>107771</ce:article-number><ce:pii>S2352-3409(21)01045-3</ce:pii><ce:doi>10.1016/j.dib.2021.107771</ce:doi><ce:document-thread><ce:refers-to-document id="ref0001"><ce:pii>S2352-5517(21)00059-7</ce:pii><ce:doi>10.1016/j.plabm.2021.e00259</ce:doi></ce:refers-to-document></ce:document-thread><ce:copyright type="other" year="2021">The Authors</ce:copyright></ja:item-info><ja:head><ce:dochead id="dchd0001"><ce:textfn id="dhtxt0001">Data Article</ce:textfn></ce:dochead><ce:title id="tte0002">Data on the frequency and causes of icteric interference in clinical chemistry laboratory tests</ce:title><ce:author-group id="aut0001"><ce:author id="au0001" author-id="S2352340921010453-0dc5fc373d8e81d3defdb55796bd6f6e"><ce:given-name>Anna E.</ce:given-name><ce:surname>Merrill</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/formal-analysis">Formal analysis</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/conceptualization">Conceptualization</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-original-draft">Writing &#x2013; original draft</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-review-editing">Writing &#x2013; review &amp; editing</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/methodology">Methodology</ce:contributor-role><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref><ce:e-address id="ead0001" type="email" xlink:href="mailto:anna-merrill@uiowa.edu">anna-merrill@uiowa.edu</ce:e-address></ce:author><ce:author id="au0002" author-id="S2352340921010453-8e8b2de32e0729012411366a3758b760"><ce:given-name>Sandhya</ce:given-name><ce:surname>Mainali</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/formal-analysis">Formal analysis</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-review-editing">Writing &#x2013; review &amp; editing</ce:contributor-role><ce:cross-ref refid="aff0002"><ce:sup loc="post">b</ce:sup></ce:cross-ref><ce:cross-ref refid="aff0003"><ce:sup loc="post">c</ce:sup></ce:cross-ref></ce:author><ce:author id="au0003" author-id="S2352340921010453-3e1d0e993e8b1745a70ce5fe254bdfc4"><ce:given-name>Matthew D.</ce:given-name><ce:surname>Krasowski</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/formal-analysis">Formal analysis</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/conceptualization">Conceptualization</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-original-draft">Writing &#x2013; original draft</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-review-editing">Writing &#x2013; review &amp; editing</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/methodology">Methodology</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/supervision">Supervision</ce:contributor-role><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref><ce:cross-ref refid="cor0001"><ce:sup loc="post">&#x204e;</ce:sup></ce:cross-ref><ce:e-address id="ead0002" type="email" xlink:href="mailto:mkrasows@healthcare.uiowa.edu">mkrasows@healthcare.uiowa.edu</ce:e-address><ce:e-address id="ead0003" type="email" xlink:href="mailto:matthew-krasowski@uiowa.edu">matthew-krasowski@uiowa.edu</ce:e-address></ce:author><ce:affiliation id="aff0001" affiliation-id="S2352340921010453-cb5a3cea5855dd64db720e81b6993a7a"><ce:label>a</ce:label><ce:textfn id="cetextfn0001">Department of Pathology, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, C-671 GH, Iowa City, IA 52242, USA</ce:textfn><sa:affiliation><sa:organization>Department of Pathology</sa:organization><sa:organization>University of Iowa Hospitals and Clinics</sa:organization><sa:address-line>200 Hawkins Drive, C-671 GH</sa:address-line><sa:city>Iowa City</sa:city><sa:state>IA</sa:state><sa:postal-code>52242</sa:postal-code><sa:country>USA</sa:country></sa:affiliation><ce:source-text id="staff0001">aDepartment of Pathology, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, C-671 GH, Iowa City, IA 52242, USA</ce:source-text></ce:affiliation><ce:affiliation id="aff0002" affiliation-id="S2352340921010453-b519a6adad374a7d0525e73f92050432"><ce:label>b</ce:label><ce:textfn id="cetextfn0002">Carver College of Medicine, University of Iowa, 451 Newton Road, Iowa City, IA 52242, USA</ce:textfn><sa:affiliation><sa:organization>Carver College of Medicine</sa:organization><sa:organization>University of Iowa</sa:organization><sa:address-line>451 Newton Road</sa:address-line><sa:city>Iowa City</sa:city><sa:state>IA</sa:state><sa:postal-code>52242</sa:postal-code><sa:country>USA</sa:country></sa:affiliation><ce:source-text id="staff0002">bCarver College of Medicine, University of Iowa, 451 Newton Road, Iowa City, IA 52242, USA</ce:source-text></ce:affiliation><ce:affiliation id="aff0003" affiliation-id="S2352340921010453-988d98e7b8c8632d96eb703e357040a4"><ce:label>c</ce:label><ce:textfn id="cetextfn0003">Department of Psychiatry and Behavioral Sciences, University of Kansas School of Medicine-Wichita, Wichita, KS 67214, USA</ce:textfn><sa:affiliation><sa:organization>Department of Psychiatry and Behavioral Sciences</sa:organization><sa:organization>University of Kansas School of Medicine-Wichita</sa:organization><sa:city>Wichita</sa:city><sa:state>KS</sa:state><sa:postal-code>67214</sa:postal-code><sa:country>USA</sa:country></sa:affiliation><ce:source-text id="staff0003">cDepartment of Psychiatry and Behavioral Sciences, University of Kansas School of Medicine-Wichita, Wichita, KS 67214, USA</ce:source-text></ce:affiliation><ce:correspondence id="cor0001"><ce:label>&#x204e;</ce:label><ce:text id="cetext0001">Corresponding author.</ce:text></ce:correspondence></ce:author-group><ce:date-received day="17" month="11" year="2021"/><ce:date-revised day="22" month="12" year="2021"/><ce:date-accepted day="27" month="12" year="2021"/><ce:abstract id="abs0001" view="all" class="author"><ce:section-title id="cesectitle0001">Abstract</ce:section-title><ce:abstract-sec id="abss0001" view="all"><ce:simple-para id="spara001" view="all">The presence of elevated levels of bilirubin (icterus) in serum or plasma specimens has the potential to interfere with clinical chemistry and other laboratory assays. Along with hemolysis and lipemia, icterus represents one of the most common endogenous interferences with laboratory tests. There are two common mechanisms by which icterus can cause assay interference. The first common mechanism is spectral interference due to absorption at wavelengths used in assays by bilirubin and/or bilirubin breakdown products. The second common mechanism involves chemical reaction of bilirubin with the reagents used in some enzymatic assays. Most automated clinical chemistry platforms can perform rapid estimates of indices for hemolysis, icterus, and lipemia (HIL), typically by measuring absorbance at wavelengths impacted by these interferences. The data in this article provides results from a detailed 12-month retrospective review of icteric indices and the impact on 114 clinical chemistry assays at an academic medical center in the United States. The data include 414,502 specimens from 94,081 unique patients (51,851 females; 42,230 males), with a total of 2,791,591 discrete clinical chemistry assays performed on the specimens. Detailed chart review was performed for all patients who had one or more specimens with an icteric index of 40 or higher (&#x2018;severe icterus&#x2019;), including determination of the medical diagnoses likely causing icterus and the mortality of these patients within 1 and 3 years following laboratory testing. Data for all specimens include patient location at time of testing (emergency department, inpatient unit, or outpatient site), sex, age, HIL indices, specific clinical chemistry assays performed, and number of times specimens had icteric indices exceeding the icteric index threshold in the package inserts for the clinical chemistry assays performed. The dataset reported is related to the research entitled &#x201c;Frequency of Icteric Interference in Clinical Chemistry Laboratory Tests and Causes of Severe Icterus&#x201d; [S. Mainali, A.E. Merrill, M.D. Krasowski, Frequency of icteric interference in clinical chemistry laboratory tests and causes of severe icterus, Pract. Lab. Med. (2021) 27: e00259]</ce:simple-para></ce:abstract-sec></ce:abstract><ce:keywords id="keys0001" view="all" class="keyword"><ce:section-title id="cesectitle0002">Keywords</ce:section-title><ce:keyword id="key0001"><ce:text id="cetext0002">Alcoholic liver disease</ce:text></ce:keyword><ce:keyword id="key0002"><ce:text id="cetext0003">Biliary tract diseases</ce:text></ce:keyword><ce:keyword id="key0003"><ce:text id="cetext0004">Bilirubin</ce:text></ce:keyword><ce:keyword id="key0004"><ce:text id="cetext0005">Clinical chemistry tests</ce:text></ce:keyword><ce:keyword id="key0005"><ce:text id="cetext0006">Jaundice</ce:text></ce:keyword><ce:keyword id="key0006"><ce:text id="cetext0007">Viral hepatitis</ce:text></ce:keyword></ce:keywords></ja:head></ja:article></doc:document>
